Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CXCL2 Polyclonal Antibody, Invitrogen™
Goat Polyclonal Antibody
Supplier: Thermo Scientific PA519126
Description
This antibody is tested in Peptide ELISA: antibody detection limit dilution 32,000.
Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.
Specifications
CXCL2 | |
Polyclonal | |
Unconjugated | |
Cxcl2 | |
C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 2; CINC-2a; Cinc3; CINC-3; CXC; CXC motif chemokine; C-X-C motif chemokine 2; C-X-C motif chemokine ligand 2; CXCL; CXCL2; Cytokine-induced neutrophil chemoattractant 3; GRO b; gro beta; GRO β; GRO2; GRO2 oncogene; GROb; GRObeta; gro-beta; GRO-beta(5-73); GRO-beta-T; Growth-regulated protein beta; GROβ; Hematopoietic synergistic factor; HSF; Macrophage inflammatory protein 2; macrophage inflammatory protein 2-alpha; melanoma growth stimulatory activity beta; MGSA beta; Mgsa-b; MIP 2 a; MIP 2 alpha; MIP 2 a; Mip2; MIP-2; MIP2 a; MIP2 a; MIP2A; MIP-2a; MIP2-alpha; SB-251353; Scyb; Scyb2; small inducible cytokine subfamily, member 2 | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
2920 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
P19875 | |
Cxcl2 | |
Synthetic peptide sequence (KKIIEKMLKNGKSN) corresponding to the C-terminus amino acids of CXCL2 | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction